2024 Q3 Form 10-Q Financial Statement

#000121390024068239 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $7.502M $4.700M
YoY Change -14.22% -23.3%
Cost Of Revenue $1.847M $1.709M
YoY Change 2.04% 7.64%
Gross Profit $5.655M $2.991M
YoY Change -18.4% -34.12%
Gross Profit Margin 75.38% 63.64%
Selling, General & Admin $8.604M $7.199M
YoY Change -30.67% -32.68%
% of Gross Profit 152.16% 240.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.202M $4.181M
YoY Change -7.85% 23.96%
% of Gross Profit 74.31% 139.81%
Operating Expenses $14.65M $13.09M
YoY Change -21.99% -16.39%
Operating Profit -$7.151M -$8.390M
YoY Change -28.76% -11.94%
Interest Expense -$7.042M -$7.596M
YoY Change -216.85% 114.39%
% of Operating Profit
Other Income/Expense, Net $2.731M -$7.099M
YoY Change -144.58% 88.5%
Pretax Income -$4.420M -$15.49M
YoY Change -72.65% 16.52%
Income Tax
% Of Pretax Income
Net Earnings -$4.420M -$15.49M
YoY Change -72.65% 16.52%
Net Earnings / Revenue -58.92% -329.58%
Basic Earnings Per Share -$0.72 -$2.41
Diluted Earnings Per Share -$0.72 -$2.41
COMMON SHARES
Basic Shares Outstanding 6.552M shares 6.526M shares
Diluted Shares Outstanding 6.551M shares 6.528M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.569M $1.455M
YoY Change -40.25% -84.37%
Cash & Equivalents $7.484M $6.443M
Short-Term Investments
Other Short-Term Assets $7.840M $7.147M
YoY Change 124.0% 114.08%
Inventory
Prepaid Expenses
Receivables $1.660M $1.131M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.07M $9.733M
YoY Change 4.95% -36.33%
LONG-TERM ASSETS
Property, Plant & Equipment $335.1M $339.2M
YoY Change -8.94% -8.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.363M $2.411M
YoY Change -59.25% -86.69%
Other Assets $4.915M $4.988M
YoY Change -34.47% -33.87%
Total Long-Term Assets $423.6M $427.2M
YoY Change -2.75% -1.98%
TOTAL ASSETS
Total Short-Term Assets $12.07M $9.733M
Total Long-Term Assets $423.6M $427.2M
Total Assets $435.6M $436.9M
YoY Change -2.55% -3.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.94M $26.67M
YoY Change -13.14% 65.76%
Accrued Expenses $3.400M $3.326M
YoY Change -0.01% -2.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.25M $32.86M
YoY Change -71.47% -59.54%
LONG-TERM LIABILITIES
Long-Term Debt $310.5M $296.9M
YoY Change 53.47% 52.07%
Other Long-Term Liabilities $6.226M $8.970M
YoY Change -48.55% -39.52%
Total Long-Term Liabilities $316.7M $305.9M
YoY Change 47.71% 45.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.25M $32.86M
Total Long-Term Liabilities $316.7M $305.9M
Total Liabilities $341.9M $338.8M
YoY Change 12.89% 16.29%
SHAREHOLDERS EQUITY
Retained Earnings -$252.0M -$247.3M
YoY Change 28.26% 37.34%
Common Stock $655.00 $655.00
YoY Change 15.52% 15.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $94.67M $99.13M
YoY Change
Total Liabilities & Shareholders Equity $435.6M $436.9M
YoY Change -2.55% -3.14%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$4.420M -$15.49M
YoY Change -72.65% 16.52%
Depreciation, Depletion And Amortization $4.202M $4.181M
YoY Change -7.85% 23.96%
Cash From Operating Activities -$1.816M -$2.833M
YoY Change -2694.06% -65.19%
INVESTING ACTIVITIES
Capital Expenditures $5.405M $811.1K
YoY Change -70.22% -91.89%
Acquisitions
YoY Change
Other Investing Activities $500.0K $1.510K
YoY Change -96.02% -99.99%
Cash From Investing Activities -$4.905M -$809.6K
YoY Change -12.41% -107.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.762M 3.202M
YoY Change 1705.04% 3898.11%
NET CHANGE
Cash From Operating Activities -1.816M -2.833M
Cash From Investing Activities -4.905M -809.6K
Cash From Financing Activities 7.762M 3.202M
Net Change In Cash 1.041M -440.8K
YoY Change -120.41% -120.5%
FREE CASH FLOW
Cash From Operating Activities -$1.816M -$2.833M
Capital Expenditures $5.405M $811.1K
Free Cash Flow -$7.221M -$3.644M
YoY Change -60.06% -79.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
001-38363
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2024Q2 hofv Undesignated Preferred Stock
UndesignatedPreferredStock
usd
CY2024Q2 hofv Undesignated Preferred Stock Shares Issued
UndesignatedPreferredStockSharesIssued
shares
CY2024Q2 hofv Undesignated Preferred Stock Shares Outstanding
UndesignatedPreferredStockSharesOutstanding
shares
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
HALL OF FAME RESORT & ENTERTAINMENT COMPANY
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3235695
dei Entity Address Address Line1
EntityAddressAddressLine1
2014 Champions Gateway
dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44708
dei City Area Code
CityAreaCode
(330)
dei Local Phone Number
LocalPhoneNumber
458–9176
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6551567 shares
CY2024Q2 us-gaap Cash
Cash
1455207 usd
CY2023Q4 us-gaap Cash
Cash
3243353 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
4988158 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8572730 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
2410619 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
1131364 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1108460 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
7146820 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3514135 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
339210450 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
344378835 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
12325227 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7231656 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7387693 usd
CY2024Q2 hofv Project Development Costs
ProjectDevelopmentCosts
71367323 usd
CY2023Q4 hofv Project Development Costs
ProjectDevelopmentCosts
59366200 usd
CY2024Q2 us-gaap Assets
Assets
436941597 usd
CY2023Q4 us-gaap Assets
Assets
441896633 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
229184587 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
219532941 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26670454 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
21825540 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
2862942 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
1293874 usd
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
177000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
225000 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
67758996 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
62982552 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3326074 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3440630 usd
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
8793397 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
5858682 usd
CY2024Q2 us-gaap Liabilities
Liabilities
338773450 usd
CY2023Q4 us-gaap Liabilities
Liabilities
315159219 usd
CY2024Q2 hofv Undesignated Preferred Stock Par Or Stated Value Per Share
UndesignatedPreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 hofv Undesignated Preferred Stock Par Or Stated Value Per Share
UndesignatedPreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 hofv Undesignated Preferred Stock Shares Authorized
UndesignatedPreferredStockSharesAuthorized
4917000 shares
CY2023Q4 hofv Undesignated Preferred Stock Shares Authorized
UndesignatedPreferredStockSharesAuthorized
4917000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6548719 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6548719 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6437020 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6437020 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
655 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
643 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
346417368 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
344335489 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247286452 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-216643882 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
99131573 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
127692252 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-963426 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-954838 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98168147 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
126737414 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
436941597 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
441896633 usd
CY2024Q2 us-gaap Revenues
Revenues
4699669 usd
CY2023Q2 us-gaap Revenues
Revenues
6127277 usd
us-gaap Revenues
Revenues
8890984 usd
us-gaap Revenues
Revenues
9247710 usd
CY2024Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7199196 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10693853 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
13349560 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
23222569 usd
CY2024Q2 us-gaap Other General Expense
OtherGeneralExpense
1708961 usd
CY2023Q2 us-gaap Other General Expense
OtherGeneralExpense
1587620 usd
us-gaap Other General Expense
OtherGeneralExpense
2683393 usd
us-gaap Other General Expense
OtherGeneralExpense
3046823 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1145000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
4181191 usd
CY2023Q2 us-gaap Depreciation
Depreciation
3373076 usd
us-gaap Depreciation
Depreciation
8339941 usd
us-gaap Depreciation
Depreciation
5926436 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
13089348 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
15654549 usd
us-gaap Operating Expenses
OperatingExpenses
24372894 usd
us-gaap Operating Expenses
OperatingExpenses
33340828 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8389679 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9527272 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15481910 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24093118 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6475614 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4404146 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
12997148 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8036783 usd
CY2024Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1054650 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
882240 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2009972 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1738131 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
223000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-48000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
461000 usd
CY2023Q2 hofv Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
-60000 usd
hofv Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
40000 usd
CY2023Q2 hofv Change In Fair Value Of Securities Available For Sale
ChangeInFairValueOfSecuritiesAvailableForSale
-1683246 usd
hofv Change In Fair Value Of Securities Available For Sale
ChangeInFairValueOfSecuritiesAvailableForSale
-1683246 usd
CY2024Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
1502 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-138539 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3763 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3763 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
500000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
500000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-65778 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35826 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7099303 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3766140 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14637248 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8592668 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-15488982 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-13293412 usd
us-gaap Profit Loss
ProfitLoss
-30119158 usd
us-gaap Profit Loss
ProfitLoss
-32685786 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
266000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
266000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
532000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
532000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5795 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8588 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-54372 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15754982 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13553617 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30642570 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33163414 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.41
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.88
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6527988 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5660385 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6507016 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5644822 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
126737414 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
96469 usd
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
7672 shares
CY2024Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
266000 usd
CY2024Q1 hofv Adjustments To Additional Paid In Capital Modification Of Warrants In Connection With Irg Restructuring
AdjustmentsToAdditionalPaidInCapitalModificationOfWarrantsInConnectionWithIRGRestructuring
1666000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-14630176 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113603707 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
205994 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
113428 usd
CY2024Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
266000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-15488982 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98168147 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
191258112 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
651034 usd
CY2023Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
8741 shares
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
266000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-19392374 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
172250772 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1086017 usd
CY2023Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
5012 shares
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
39261 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
266000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-13293412 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
159816638 usd
us-gaap Profit Loss
ProfitLoss
-30119158 usd
us-gaap Profit Loss
ProfitLoss
-32685786 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8339941 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5926436 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2009972 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1738131 usd
us-gaap Accretion Expense
AccretionExpense
3689840 usd
us-gaap Accretion Expense
AccretionExpense
3399422 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1145000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
508610 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35826 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
6245901 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
2282040 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-138539 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3763 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-40000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
48000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-461000 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1683246 usd
us-gaap Share Based Compensation
ShareBasedCompensation
302463 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1737051 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
248841 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
258416 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
177685 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
829818 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2144476 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1143033 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1797937 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1743958 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-153214 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-159149 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
1569068 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-456167 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2950265 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2539138 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5310177 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19683133 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
64606946 usd
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
69815000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8128136 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11905537 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19676877 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3777401 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14468823 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12298391 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
22270339 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
11407206 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
783191 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1552342 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
747396 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2187500 usd
us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
3500000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
300000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
71071 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
39261 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3714860 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17486567 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5372718 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16665389 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11816083 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33516382 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6443365 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16850993 usd
CY2024Q2 us-gaap Cash
Cash
1455207 usd
CY2023Q2 us-gaap Cash
Cash
9307494 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
4988158 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
7543499 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6443365 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16850993 usd
us-gaap Interest Paid Net
InterestPaidNet
3671485 usd
us-gaap Interest Paid Net
InterestPaidNet
2644324 usd
hofv Accrued Interest Rolled Into Notes Payable In Connection With Modification
AccruedInterestRolledIntoNotesPayableInConnectionWithModification
15468785 usd
hofv Penny Warrants Received In Consideration Of Sports Betting Agreement
PennyWarrantsReceivedInConsiderationOfSportsBettingAgreement
1666000 usd
hofv Proceeds From Sale Of Assets Held In Escrow
ProceedsFromSaleOfAssetsHeldInEscrow
1500000 usd
hofv Accrued Series B Preferred Stock Dividends
AccruedSeriesBPreferredStockDividends
532000 usd
hofv Accrued Series B Preferred Stock Dividends
AccruedSeriesBPreferredStockDividends
232000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1: Organization, Nature of Business, and Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Organization and Nature of Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">Hall of Fame Resort &amp; Entertainment Company, a Delaware corporation (together with its subsidiaries, unless the context indicates otherwise, the “Company” or “HOFRE”), was incorporated in Delaware as GPAQ Acquisition Holdings, Inc., a wholly owned subsidiary of our legal predecessor, Gordon Pointe Acquisition Corp. (“GPAQ”), a special purpose acquisition company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 1, 2020, the Company consummated a business combination with HOF Village, LLC, a Delaware limited liability company (“HOF Village”), pursuant to an Agreement and Plan of Merger dated September 16, 2019 (as amended on November 6, 2019, March 10, 2020 and May 22, 2020, the “Merger Agreement”), by and among the Company, GPAQ, GPAQ Acquiror Merger Sub, Inc., a Delaware corporation (“Acquiror Merger Sub”), GPAQ Company Merger Sub, LLC, a Delaware limited liability company (“Company Merger Sub”), HOF Village and HOF Village Newco, LLC, a Delaware limited liability company (“Newco”). The transactions contemplated by the Merger Agreement are referred to as the “Business Combination”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a resort and entertainment company leveraging the power and popularity of professional football and its legendary players in partnership with the National Football Museum, Inc., doing business as the Pro Football Hall of Fame (“PFHOF”). Headquartered in Canton, Ohio, the Company owns the DoubleTree by Hilton located in downtown Canton and the Hall of Fame Village, which is a multi-use sports, entertainment, and media destination centered around the PFHOF’s campus. The Company is pursuing a differentiation strategy across three business verticals, including destination-based assets, HOF Village Media Group, LLC (“Hall of Fame Village Media”), and gaming (“Gold Summit Gaming”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">The Company has entered into multiple agreements with PFHOF, and certain government entities, which outline the rights and obligations of each of the parties with regard to the property on which the Hall of Fame Village sits, portions of which are owned by the Company and portions of which are net leased to the Company by government and quasi-governmental entities (see Note 9 for additional information). Under these agreements, the PFHOF and the lessor entities are entitled to use portions of the Hall of Fame Village on a direct-cost basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Liquidity and Going Concern</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has sustained recurring losses through June 30, 2024 and the Company’s accumulated deficit was $247.3 million as of such date. Since inception, the Company’s operations have been funded principally through the issuance of debt and equity. As of June 30, 2024, the Company had approximately $1.5 million of unrestricted cash and $5.0 million of restricted cash. During the six months ended June 30, 2024, the Company used cash for operating activities of $5.3 million. The Company has approximately $99.9 million of debt coming due through August 14, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects that it will need to raise additional financing to accomplish its development plan and fund its working capital. The Company is seeking to obtain additional funding through debt, construction lending, and equity financing. There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to meet its obligations as they come due for at least one year from the issuance of these condensed consolidated financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p>
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247300000 usd
CY2024Q2 hofv Unrestricted Cash
UnrestrictedCash
1500000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
5000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5300000 usd
CY2024Q2 us-gaap Debt Securities
DebtSecurities
99900000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Reclassification</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain financial statement line items of the Company’s historical presentation have been reclassified to conform to the corresponding financial statement line items. These reclassifications have no material impact on the historical operating loss, net loss, total assets, total liabilities, or stockholders’ equity previously reported.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates and assumptions for the Company relate to credit losses, depreciation, costs capitalized to project development costs, useful lives of long-lived assets, impairment, stock-based compensation, and fair value of financial instruments (including the fair value of the Company’s warrant liability). Management adjusts such estimates when facts and circumstances dictate. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
4988158 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8572730 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
330332 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
243081 usd
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.50 pure
us-gaap Payments For Film Costs
PaymentsForFilmCosts
0 usd
us-gaap Payments For Film Costs
PaymentsForFilmCosts
1305000 usd
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
177000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
225000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14663374 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6102409 shares
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
418558184 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
433450980 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79347734 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
76746918 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
339210450 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
356704062 usd
CY2024Q2 hofv Project Development Costs
ProjectDevelopmentCosts
71367323 usd
CY2023Q4 hofv Project Development Costs
ProjectDevelopmentCosts
59366200 usd
CY2024Q1 hofv Interest Rate Of Held For Sale
InterestRateOfHeldForSale
0.80 pure
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
12325227 usd
CY2024Q2 us-gaap Depreciation
Depreciation
4181191 usd
CY2023Q2 us-gaap Depreciation
Depreciation
3373076 usd
us-gaap Depreciation
Depreciation
8339941 usd
us-gaap Depreciation
Depreciation
5926436 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
13814619 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
19676877 usd
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
1813496 usd
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
127045169 usd
CY2024Q2 us-gaap Theatrical Film Costs Development
TheatricalFilmCostsDevelopment
200000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
236686139 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7501552 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
229184587 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
229185010 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9652069 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
219532941 usd
CY2024Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1054650 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
882240 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2009972 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1738131 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
6245901 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
2282040 usd
CY2024Q2 us-gaap Long Term Debt Maturity Date
LongTermDebtMaturityDate
2030-07-01
CY2024Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1519049 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
804713 usd
srt Interest Bearing Liabilities Average Rate Paid
InterestBearingLiabilitiesAverageRatePaid
0.05 pure
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3763 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1830000 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2000000 usd
CY2024Q1 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.0265 pure
CY2020Q3 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
82397 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
181818 shares
CY2023Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
275000 shares
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
89006 shares
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
110000 shares
CY2023Q4 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
39016766 usd
CY2023Q4 hofv Underwriting Agreement Duration Period
UnderwritingAgreementDurationPeriod
P90D
CY2024Q2 hofv Net Proceeds Of Equity Distribution Agreement
NetProceedsOfEquityDistributionAgreement
113428 usd
hofv Net Proceeds Of Equity Distribution Agreement
NetProceedsOfEquityDistributionAgreement
113428 usd
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
14543722 usd
CY2024Q2 hofv Performance Stock Unit Threshold Percentage
PerformanceStockUnitThresholdPercentage
0.50 pure
CY2024Q1 hofv Performance Stock Unit
PerformanceStockUnit
8896 shares
hofv Relative Rights Of Equity Percentage
RelativeRightsOfEquityPercentage
0.07 pure
CY2023Q1 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1600000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
800 shares
CY2023Q1 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
800000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
800 shares
CY2023Q2 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
800000 usd
CY2024Q2 hofv Sponsor Revenue Received Due Remainder Of Fiscal Year
SponsorRevenueReceivedDueRemainderOfFiscalYear
722025 usd
CY2024Q2 hofv Sponsor Revenue Received Due One Year
SponsorRevenueReceivedDueOneYear
1983265 usd
CY2024Q2 hofv Sponsor Revenue Received Due Two Year
SponsorRevenueReceivedDueTwoYear
1909027 usd
CY2024Q2 hofv Sponsor Revenue Received Due Three Year
SponsorRevenueReceivedDueThreeYear
1388515 usd
CY2024Q2 hofv Sponsor Revenue Received Due Four Year
SponsorRevenueReceivedDueFourYear
1257265 usd
CY2024Q2 hofv Sponsor Revenue Received Due Thereafter
SponsorRevenueReceivedDueThereafter
1257265 usd
CY2024Q2 hofv Sponsor Revenue Received
SponsorRevenueReceived
8517362 usd
CY2020Q4 hofv Agreement Term
AgreementTerm
P10Y
CY2022Q3 hofv Online Market Access Agreement Term
OnlineMarketAccessAgreementTerm
P10Y
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3600000 usd
CY2024Q2 hofv Activation Fund Reserves
ActivationFundReserves
211155 usd
CY2023Q4 hofv Activation Fund Reserves
ActivationFundReserves
126685 usd
CY2024Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
8217542 usd
CY2023Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
5441640 usd
CY2024Q2 us-gaap Deposit Liability Current
DepositLiabilityCurrent
364700 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
290357 usd
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
8793397 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
5858682 usd
CY2024Q2 hofv Grant Received
GrantReceived
500000 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8: Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the normal course of its business, the Company is subject to occasional legal proceedings and claims. The Company does not have any pending litigation that, separately or in the aggregate, would, in the opinion of management, have a material adverse effect on its results of operations, financial condition, or cash flows.</p>
CY2024Q2 us-gaap Loans Payable
LoansPayable
2862942 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
1293874 usd
CY2024Q2 hofv Percentage Of Development Costs
PercentageOfDevelopmentCosts
0.04 pure
CY2024Q2 us-gaap Other Commitments Future Minimum Payments Remainder Of Fiscal Year
OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear
600000 usd
CY2024Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
600000 usd
CY2024Q2 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
600000 usd
CY2024Q2 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
600000 usd
CY2024Q2 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
750000 usd
CY2024Q2 us-gaap Other Commitment Due After Fifth Year
OtherCommitmentDueAfterFifthYear
6000000 usd
CY2024Q2 us-gaap Other Commitment
OtherCommitment
9150000 usd
CY2024Q2 hofv Annual License Fee
AnnualLicenseFee
0 usd
CY2023Q2 hofv Annual License Fee
AnnualLicenseFee
0 usd
hofv Annual License Fee
AnnualLicenseFee
0 usd
hofv Annual License Fee
AnnualLicenseFee
300000 usd
CY2024Q2 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
28000000 usd
CY2024Q2 us-gaap Area Of Land
AreaOfLand
1.64 sqm
hofv Percentage Of Bear Interest
PercentageOfBearInterest
0.125 pure
CY2024Q2 us-gaap Percentage Of Unamortized Film Costs
PercentageOfUnamortizedFilmCosts
0.25 pure
CY2023Q2 hofv Common Stock Issued To Related Party Maximum Requirement Percentage
CommonStockIssuedToRelatedPartyMaximumRequirementPercentage
0.1999 pure
hofv Annual Fees
AnnualFees
50000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7231656 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7387693 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3326074 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3440630 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
248841 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
258416 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-153214 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-159149 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P90Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P91Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
153214 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
304603 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
301400 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
301400 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
328600 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
39116467 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
40505684 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37179610 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3326074 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
82192076 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
79219467 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
6857434 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
5056214 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
75334642 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
74163253 usd
CY2024Q2 us-gaap Lease Income
LeaseIncome
428685 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
82611 usd
us-gaap Lease Income
LeaseIncome
1070262 usd
us-gaap Lease Income
LeaseIncome
177151 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
594865 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
1174695 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
1184837 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
1170697 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
1002686 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
4216921 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
9344701 usd
CY2022Q3 us-gaap Sale Leaseback Transaction Lease Term
SaleLeasebackTransactionLeaseTerm
P99Y
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
307125 usd
CY2022Q3 hofv Annual Increases
AnnualIncreases
0.02 pure
CY2022Q4 us-gaap Payments For Rent
PaymentsForRent
4375000 usd
CY2024Q2 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.1025 pure
CY2024Q1 us-gaap Tenant Improvements
TenantImprovements
2500000 usd
CY2024Q1 us-gaap Beneficial Interest
BeneficialInterest
20 usd
CY2024Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
890313 shares
CY2024Q1 hofv Warrants Pursuant
WarrantsPursuant
0.90 pure
CY2024Q2 hofv Rent Not Paid
RentNotPaid
1197907 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
67758996 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2324731722 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2256972726 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
61299829 usd
us-gaap Lease Cost
LeaseCost
2201892776 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2140592947 usd
CY2024Q1 hofv Purchase Price Of Sale On Business
PurchasePriceOfSaleOnBusiness
10000000 usd
CY2024Q1 hofv Amount Of Increments
AmountOfIncrements
500000 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-140041 usd
us-gaap Business Combination Price Of Acquisition Expected
BusinessCombinationPriceOfAcquisitionExpected
10000000 usd
hofv Business Combination Workingcapitaladjustment
BusinessCombinationWorkingcapitaladjustment
214222 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
9785778 usd
hofv Business Acquisition Transaction Costs
BusinessAcquisitionTransactionCosts
159144 usd
hofv Business Combination Book Value Of Net Assets Sold
BusinessCombinationBookValueOfNetAssetsSold
12213120 usd
hofv Business Combination Investment Retained
BusinessCombinationInvestmentRetained
2446445 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-140041 usd
CY2024Q2 us-gaap Grants Receivable
GrantsReceivable
9800000 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2024Q2 hofv Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
usd
CY2024Q2 hofv Change In Fair Value Of Securities Available For Sale
ChangeInFairValueOfSecuritiesAvailableForSale
usd
CY2023Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.39
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.88
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5644822 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5660385 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6507016 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6527988 shares
CY2024Q1 hofv Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
usd
CY2024Q2 hofv Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2024Q2 hofv Automatic Conversion Of Series B Preferred Stock
AutomaticConversionOfSeriesBPreferredStock
usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q1 hofv Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
usd
CY2023Q1 hofv Stock Issued During Period Vlaue Cancellation Of Fractional
StockIssuedDuringPeriodVlaueCancellationOfFractional
usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q2 hofv Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
usd
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
usd
us-gaap Payments Of Dividends
PaymentsOfDividends
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
hofv Accrued Interest Rolled Into Notes Payable In Connection With Modification
AccruedInterestRolledIntoNotesPayableInConnectionWithModification
usd
hofv Penny Warrants Received In Consideration Of Sports Betting Agreement
PennyWarrantsReceivedInConsiderationOfSportsBettingAgreement
usd
hofv Proceeds From Sale Of Assets Held In Escrow
ProceedsFromSaleOfAssetsHeldInEscrow
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001708176

Files In Submission

Name View Source Status
0001213900-24-068239-index-headers.html Edgar Link pending
0001213900-24-068239-index.html Edgar Link pending
0001213900-24-068239.txt Edgar Link pending
0001213900-24-068239-xbrl.zip Edgar Link pending
ea0210409-10q_hall.htm Edgar Link pending
ea021040901ex31-1_hall.htm Edgar Link pending
ea021040901ex31-2_hall.htm Edgar Link pending
ea021040901ex32_hall.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hofv-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ea0210409-10q_hall_htm.xml Edgar Link completed
hofv-20240630_cal.xml Edgar Link unprocessable
hofv-20240630_def.xml Edgar Link unprocessable
hofv-20240630_lab.xml Edgar Link unprocessable
hofv-20240630_pre.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable